BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23305161)

  • 1. Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
    Jones RB; Leal FE; Hasenkrug AM; Segurado AC; Nixon DF; Ostrowski MA; Kallas EG
    J Negat Results Biomed; 2013 Jan; 12():3. PubMed ID: 23305161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
    Jones RB; John VM; Hunter DV; Martin E; Mujib S; Mihajlovic V; Burgers PC; Luider TM; Gyenes G; Sheppard NC; Sengupta D; Tandon R; Yue FY; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    Clin Vaccine Immunol; 2012 Feb; 19(2):288-92. PubMed ID: 22205657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
    Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
    Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.
    Perzova R; Graziano E; Sanghi S; Welch C; Benz P; Abbott L; Lalone D; Glaser J; Loughran T; Sheremata W; Poiesz BJ
    Virol J; 2013 Dec; 10():360. PubMed ID: 24365054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
    Dekaban GA; King EE; Arp J; Palker TJ; Rice GP
    Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators.
    Toufaily C; Landry S; Leib-Mosch C; Rassart E; Barbeau B
    Viruses; 2011 Nov; 3(11):2146-59. PubMed ID: 22163338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy.
    Perzova R; Graziano E; Sanghi S; Welch C; Benz P; Abbott L; Lalone D; Glaser J; Loughran T; Sheremata W; Poiesz BJ
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):242-9. PubMed ID: 25295378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
    de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
    Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
    Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
    Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal molecular mimicry in immune-mediated neurologic disease.
    Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
    Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
    Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
    Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
    Ruprecht K; Gronen F; Sauter M; Best B; Rieckmann P; Mueller-Lantzsch N
    J Neurovirol; 2008 Apr; 14(2):143-51. PubMed ID: 18444086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.
    Perron H; Lazarini F; Ruprecht K; Péchoux-Longin C; Seilhean D; Sazdovitch V; Créange A; Battail-Poirot N; Sibaï G; Santoro L; Jolivet M; Darlix JL; Rieckmann P; Arzberger T; Hauw JJ; Lassmann H
    J Neurovirol; 2005 Feb; 11(1):23-33. PubMed ID: 15804956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.
    Freimanis G; Hooley P; Ejtehadi HD; Ali HA; Veitch A; Rylance PB; Alawi A; Axford J; Nevill A; Murray PG; Nelson PN
    Clin Exp Immunol; 2010 Jun; 160(3):340-7. PubMed ID: 20345981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.